EHC/LinkedIn
Feb 15, 2026, 10:52
Awareness and Research on Factor V Deficiency Are Critical – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor V Deficiency
Nosebleeds that won’t stop. Bruises from nowhere.
Bleeding that just keeps going.
For people with this rare clotting disorder, these aren’t occasional issues—they’re part of life.
The condition can affect anyone at any age, but knowing the signs matters.
Right now, treatment options are limited, which is why awareness and research are so critical.
Want to learn more?
On the ERIN Focus Area page on our EHC Community website, you can find relevant webinars, podcasts, and publications.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly